Phoenicis focuses on developing therapies to provide hope and relief to people living with rare disease.
Phoenicis has raised $13.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
Phoenicis is headquartered in Hingham, United States.
Phoenicis focuses on developing therapies to provide hope and relief to people living with rare disease.
Phoenicis is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Phoenicis — Funding & Investors." VCBacked, November 21, 2025, https://www.vcbacked.co/company/phoenicis. Accessed August 18, 2026.
VCBacked. (2025). Phoenicis — Funding & Investors. Retrieved August 18, 2026, from https://www.vcbacked.co/company/phoenicis
{{cite web |title=Phoenicis — Funding & Investors |url=https://www.vcbacked.co/company/phoenicis |website=VCBacked |access-date=August 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated